ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Secrets & Pearls of Rheumatology at ACR Convergence 2025

Mithu Maheswaranathan, MD  |  November 12, 2025

Labs in Connective Tissue Disease

Dr. Pope said it is important not to order an anti-nuclear antibody (ANA) test if there is low index of suspicion because it can generate false positive results. “This may not only generate patient concern, but is a waste of resources. And don’t repeat a positive ANA; that’s a waste of money,” Dr. Pope quipped.

The extractable nuclear antigen (ENA) test can only be positive in a negative ANA patient in positive Ro/SSA patients.5 “The other positive ENA tests are irrelevant if there is a negative ANA,” Dr. Pope said. “And don’t order a dsDNA [double-stranded DNA test] if the ANA is negative, as dsDNA can only be in the nucleus.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Pope also advised to stop ordering dsDNA and complements in SLE patients if they have negative tests for several visits, unless clinically indicated.6 “The chance of converting to positive is very low if previously repeatedly negative,” she noted.

Raynaud’s Phenomenon

Dr. Pope highlighted a phone application called Magnifier that allows you to visualize nailfolds when evaluating patients with Raynaud’s phenomenon. “Abnormal nailfold capillaroscopy increases the chance of developing a future connective tissue disease,” Dr. Pope said.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Scleroderma

Interstitial lung disease in systemic sclerosis can occur at any time, in both the diffuse and limited subsets, though risk is highest in the first few years, Dr. Pope reviewed.

Sjögren’s Disease

“Repeatedly screening all patients with Sjögren’s disease for lymphoma is unnecessary,” Dr. Pope said. “This is a waste of money.” She suggested instead screening higher-risk patients, such as those with B symptoms or weight loss, or features like persistent salivary gland enlargement, low complement and positive cryoglobulins.7

Other Rheumatic Diseases

W. Winn Chatham, MD

Dr. Chatham

Walter Winn Chatham, MD, professor of internal medicine, clinical immunology and rheumatology at the Kirk Kerkorian School of Medicine, University of Nevada, Las Vegas, spoke next about clinical pearls in other rheumatic diseases.

Crystalline Arthropathy

Calcium pyrophosphate disease (CPPD) was noted to be a mimic of giant cell arteritis or polymyalgia rheumatica. For example, an elderly patient may present with shoulder/hip girdle pain and high inflammatory markers with neck pain and occipital headache, but have the crowned dens sign of CPPD on radiographs.8

Additionally, patients with gout or CPPD may present with systemic inflammatory response syndrome (SIRS)–like phenotype and high C-reactive protein levels. “Consider gout and CPPD in the differential for nosocomial fever in elderly patients, especially after infection is ruled out,” Dr. Chatham said. “Crystalline arthritis can be highly inflammatory.”

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceMeeting ReportsMyositisOther Rheumatic ConditionsSjögren’s DiseaseSystemic Lupus ErythematosusVasculitis Tagged with:ACR Convergence 2025ACR Convergence 2025 - LNconnective tissue diseaseLupusLupus nephritismyositisRaynaud’s phenomenonRheumatic DiseaseSjögren's Diseasesystemic lupus erythematosus (SLE)

Related Articles
    Editor's Pick

    A Practical Guide to Autoantibody Testing in Rheumatic Diseases

    October 7, 2024

    “ANA’s are some of most commonly ordered tests but what exactly are they and what do you do with a positive ANA? Check out the Editor’s Pick for October to learn more,” says Physician Editor Bharat Kumar, MD, MME, FACP, FAAAAI, RhMSUS.

    Systemic Lupus Erythematosus: A Complex, Multi-Challenging Disease

    November 26, 2024

    Reviewing the research presented at ACR Convergence 2024.

    Rheumatologist Richard M. Pope, MD, Was Honored at Northwestern University Symposium

    September 8, 2016

    When the head of the division steps down, how do you mark that event? The Feinberg School of Medicine, Northwestern University-Chicago hosted a day-long symposium to honor Richard M. Pope, MD, who had been chief of the division for 27 years, according to Harris Perlman, PhD, the new chief of the Division of Rheumatology. Richard…

    Lupus Nephritis: A Serious Manifestation of Systemic Lupus Erythematosus

    December 6, 2025

    This review highlights some of the many abstracts on lupus nephritis research presented at ACR Convergence 2025. They demonstrate advances made on early recognition of the condition, as well as offering some hope in terms of achieving better outcomes.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences